The latest Investing Matters Podcast episode featuring financial educator and author Jared Dillian has been released. Listen here.
I'm very happy with it - all proceeding at pace and updates expected probably next quarter regarding FUM. What do you expect, exactly? For the developments of the company to all magically line up with the date of the AGM, so they can spill the beans on all of their licensing contracts and other product developments at once? We will get told as and when there are updates, this is an AGM, not an announcement RNS.
Good to see a lot of confidence in this share. This cash injection will put Futura in a much better position for upcoming negotiations. I’m feeling quietly confident about the next 2-3 months, I think they could be pretty exciting.
Common with shares like these on a big uptrend to have a huge treeshake on market open to hit people's stop losses and free up some shares. Unfortunately my buy order at 52 didn't get hit, but onwards and upwards we go. The fundamentals have not changed, we must be at touching distance of more licensee deals in Europe and elsewhere off the back of the EMA approval. Patience will be rewarded (though so often lacked in AIM). GLA
is to top up if it ever goes below 60p, and hold through the next several months into a myriad of licensee deals across the regions outlined in the previous RNS which I'm sure will flow in now that we have EMA approval.
Short term traders and people looking to make a quick profit are welcome to have their own strategy, but taking a step back and looking at this product in the bigger picture everyone with a position is better off sitting on their hands until we hit the shelves globally (at which point I'm sure the SP will be up in the £s)
If it was to be an entire replacement for viagra the market cap should be in the billions - we don't need the entire pie, but we stand to take a hefty piece with the EMA approval completed and global licensees around the corner. MED3000 has a number of 'breakthrough' differences that set it apart as quoted in the Sun today
My last post on Friday morning after reading the RNS attracted a lot of attention, where I predicted 50p being hit within three months. We hit 50p that same afternoon. Now with this huge exposure to new investors in two national newspaper I predict £1 to be hit by the end of this coming week.
Like last time, this may be a little conservative and I hope to be proven right very shortly. GLA
I see this climbing to 50p within the next few months and announcement of the other partners hinted at in the contracts. From there, it's only a matter of time before £1- The addressable market is huge and this EU approval paves the way for a global product - things will accelerate very quickly from here I'm sure
I am not trying to offer advice so much as sharing my own reasoning for investing when reading other responses on the board relating to the efficacy. I plan to be here for the coming months, so I am not trying to ramp for any short term price movement (not that I believe these forums affect the stock price in the slightest, hence why I very rarely post), merely stating my own reasoning. Of course one should never invest more than they can afford to lose, and pharmaceutical companies in particular are at the sharper end of that statement.
I would never bet the house on a 1 in 45m lottery ticket, though if I was mathematically shown to have a >99.9% chance of winning then I'd be sure to buy a ticket. Bit of a silly comparison of course - the stock market should not be treated like the euromillions - however in this case I hope to be proved right in the coming months. DYOR and GLA!
I'm not so much trying to offer advice, just trying to show my own reasoning that I used when making my own investment after reading other's opinions on the board about the efficacy. Of course no one should bet more than they can afford to lose, and pharmaceutical companies in particular are probably at the sharper end of that statement.
I would never bet the house on a 1 in 45m lottery, but on the other hand if I was shown to mathematically have a >99.9% chance of winning I'd be sure to buy a ticket. Bit of a silly comparison of course, and investing shouldn't be treated like the euromillions, but in this case I hope to be proven right. DYOR and GLA!
Research the meaning of a p value, and re-read the RNS detailing the FM57 trial results.
"""
MED3000 achieved all co-primary clinical endpoints against before treatment (baseline) with highly statistically significant p values of less than 0.001 in all instances
"""
There should be zero doubt in anyone's mind about the efficacy of MED3000 (if that is the product that you are referring to). A p value of less than 0.001 implies a less than 0.1% chance that the results occurred by chance, less than 1/1000.
This is still very under the radar.
I'm betting on a steady rise up over the next few weeks, and if more regional contracts are announced or even the EMA approval this should fly sky high as more people pile in
I'm quite new to this share but seem to have got in at a very exciting time
James Sharpe, developmental biologist
https://dev.biologists.org/content/145/18/dev170472
If the professional still has confidence then this just shows how undervalued this company is
Great interview, should see nice rise tomorrow
https://www.proactiveinvestors.co.uk/companies/news/942618/braveheart-investments--paraytec-present-their-operational-covid-19-sample-testing-pipeline-942618.html